Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : biotech insider sells -- Ignore unavailable to you. Want to Upgrade?

To: Icebrg who wrote (15)	1/28/2004 12:26:43 PM
From: tuck	Respond to of 32

Well, sometimes I wonder if there's much predictive power to biotech insider selling. The track record for buying is better, both in general and for the industry, IMO. FRX and GENZ insiders have been selling pretty steadily for the past year, too -- including a couple of pretty big chunks in the last couple of days for each -- but during that year the stocks have performed well. Meanwhile, KOSN busts through $10 to $13. But there haven't been any sells for a couple of months, after a steady tide of it at low prices before then. KOSN insiders must be either stupid or living beyond their means so they only care about immediate gratification. I guess they did their Christmas shopping early. It might be worth knowing when they have to send their kids to college. I'd expect more oblivious selling at that point, for at least four years. Perhaps the NPSP folks are similar stripes. They live in Utah, so it can't be for the beer money. Cheers, Tuck